CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Cash flows from operating activities:
Net income (loss)	$ 7,343	$ (88,903)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization	137,855	133,912
Non-cash rental and related revenues	4,970	10,113
Non-cash interest income	(1,683)	(1,444)
Non-cash interest expense	8,300	5,389
Stock-based compensation expense	5,367	6,987
Loss on extinguishment of debt	411	1,760
(Recovery of) provision for loan losses and other reserves	(12)	1,890
Net loss on sales of real estate	4,581	1,784
Impairment of real estate	72,602	495
Other-than-temporary impairment of unconsolidated joint venture	0	164,126
Loss from unconsolidated joint ventures	9,715	14,691
Other non-cash items	2,167	0
Changes in operating assets and liabilities:
Accounts receivable, prepaid expenses and other assets, net	(5,631)	13,062
Accounts payable and accrued liabilities	2,161	(5,403)
Net cash provided by operating activities	248,146	258,459
Cash flows from investing activities:
Acquisition of real estate	(83,985)	(62,116)
Origination and fundings of loans receivable	(4,500)	0
Origination and fundings of preferred equity investments	(5,813)	(4,153)
Additions to real estate	(33,809)	(29,278)
Escrow deposits for potential investments	(836)	0
Repayments of loans receivable	4,885	2,432
Repayments of preferred equity investments	4,173	683
Investment in unconsolidated joint venture	(128,019)	0
Net proceeds from the sales of real estate	62,816	15,066
Net cash used in investing activities	(185,088)	(77,366)
Cash flows from financing activities:
Net borrowings from revolving credit facility	147,353	0
Proceeds from issuance of senior unsecured notes	0	791,520
Principal payments on term loans	(63,750)	(455,000)
Principal payments on secured debt	(17,030)	(2,185)
Payments of deferred financing costs	(6)	(7,444)
Payment of contingent consideration	(2,500)	0
Issuance of common stock, net	(4,394)	172,188
Dividends paid on common stock	(207,861)	(194,311)
Net cash (used in) provided by financing activities	(148,188)	304,768
Net (decrease) increase in cash, cash equivalents and restricted cash	(85,130)	485,861
Effect of foreign currency translation on cash, cash equivalents and restricted cash	392	34
Cash, cash equivalents and restricted cash, beginning of period	115,886	65,523
Cash, cash equivalents and restricted cash, end of period	31,148	551,418
Supplemental disclosure of cash flow information:
Interest paid	68,778	66,051
Supplemental disclosure of non-cash investing activities:
Decrease in loans receivable and other investments due to acquisition of real estate	$ 14,311	$ 0